Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the consistency of response for Treximet (formerly
known as Trexima) when treating four acute migraine attacks at the mild pain phase and within
1 hour of onset of head pain.